Ligand · A1AKO
A1AKO · (4S)-3-(4-chlorophenyl)-N'-[(1E)-ethanimidoyl]-4-phenyl-N-[4-(trifluoromethyl)benzene-1-sulfonyl]-4,5-dihydro-1H-pyrazole-1-carboximidamide
A1AKO, (4S)-3-(4-chlorophenyl)-N'-[(1E)-ethanimidoyl]-4-phenyl-N-[4-(trifluoromethyl)benzene-1-sulfonyl]-4,5-dihydro-1H-pyrazole-1-carboximidamide (C25 H21 Cl F3 N5 O2 S, 548.0 g/mol), in the MolNFT structures on GenesisL1: bound in 1…
- Component
- A1AKO
- Formula
- C25 H21 Cl F3 N5 O2 S
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
A1AKO in 1 structure; the first of them:
- 9B9Z · Structural mechanism of CB1R binding to peripheral and biased inverse agonists · A1AKO R1201 · binds PHE102, MET103, ASP104, ILE105, ILE119, LEU122, SER123, GLY166 and 13 more
Residues it binds most
PHE 1, ILE 1, MET 1, LEU 1, SER 1, ALA 1, ASP 1, CYS 1, GLY 1, THR 1 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.